Mirae Asset Global Investments
BDTX icon

Mirae Asset Global Investments’s Black Diamond Therapeutics BDTX Stock Holding History

Mirae Asset Global Investments’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Sell
2,563
-409
-14% -$1K ﹤0.01% 1628
2026
Q1 		$6.33K Buy
2,972
+203
+7% +$483 ﹤0.01% 1523
2025
Q4 		$6.73K Buy
+2,769
New +$9.81K ﹤0.01% 1622

Other funds holding BDTX

DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Mirae Asset Global Investments's BDTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Black Diamond Therapeutics (BDTX) stake by 14% in Q2 2026, selling an estimated $1K and leaving 2,563 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Mirae Asset Global Investments first reported a position in BDTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.73K in Q4 2025. 15 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Mirae Asset Global Investments held 2,563 shares of Black Diamond Therapeutics worth $4.74K as of Q2 2026.
  • Mirae Asset Global Investments sold 409 Black Diamond Therapeutics shares in Q2 2026, an estimated $1K.
  • Black Diamond Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1628 holding.
  • Mirae Asset Global Investments first reported a position in Black Diamond Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Black Diamond Therapeutics position peaked at $6.73K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.